Cargando…

Infections in Patients with Cystic Fibrosis: Diagnostic Microbiology Update

Survival has improved in patients with cystic fibrosis (CF), in part because of aggressive antimicrobial management. Two multidrug-resistant environmental bacteria, the Burkholderia cepacia group and nontuberculous mycobacteria, have emerged. Improving genomic and proteomic technologies are allowing...

Descripción completa

Detalles Bibliográficos
Autor principal:	Gilligan, Peter H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115738/ https://www.ncbi.nlm.nih.gov/pubmed/24856524 http://dx.doi.org/10.1016/j.cll.2014.02.001

Ejemplares similares

The microbiology associated with cystic fibrosis
por: McGowan, Karin L.
Publicado: (1988)

Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
por: Lambiase, Antonietta, et al.
Publicado: (2006)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
por: Petrocheilou, Argyri, et al.
Publicado: (2022)

Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients
por: Al-momani, H., et al.
Publicado: (2016)

Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices
por: Caballero, Juan de Dios, et al.
Publicado: (2014)

Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem
por: Riquena, Barbara, et al.
Publicado: (2019)

Liver Disease in Cystic Fibrosis: an Update
por: Parisi, Giuseppe Fabio, et al.
Publicado: (2013)

Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta
por: Wagner, Mitchell J., et al.
Publicado: (2023)

Update on Key Emerging Challenges in Cystic Fibrosis
por: Jennings, Mark T., et al.
Publicado: (2014)

Update on the management of vitamins and minerals in cystic fibrosis
por: Sankararaman, Senthilkumar, et al.
Publicado: (2022)

Clinical, genetic and microbiological characterization of pediatric patients with cystic fibrosis in a public Hospital in Ecuador
por: Lascano-Vaca, Yazmina, et al.
Publicado: (2020)

Update on Respiratory Fungal Infections in Cystic Fibrosis Lung Disease and after Lung Transplantation
por: Renner, Sabine, et al.
Publicado: (2020)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

Infections in cystic fibrosis
por: Marks-Austin, Kathy A., et al.
Publicado: (1995)

Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: An Update on the Newest Diagnostic Tools and Therapeutic Approaches
por: Lattanzi, Claudia, et al.
Publicado: (2020)

Microbiology of the middle meatus compared to sputum in young patients with cystic fibrosis from Bahia – Brazil
por: Tunes, Alessandro, et al.
Publicado: (2013)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
por: Lee, Jung M., et al.
Publicado: (2012)

Update on Calcium Signaling in Cystic Fibrosis Lung Disease
por: Rimessi, Alessandro, et al.
Publicado: (2021)

Cystic fibrosis-related diabetes and lung disease: an update
por: Prentice, Bernadette J., et al.
Publicado: (2021)

Immunoglobulin levels, cytology and microbiologic investigations of broncho-alveolar lavage in children with cystic fibrosis
por: Petrova, Guergana, et al.
Publicado: (2013)

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
por: Albon, Dana, et al.
Publicado: (2023)

Quantitative Framework for Model Evaluation in Microbiology Research Using Pseudomonas aeruginosa and Cystic Fibrosis Infection as a Test Case
por: Cornforth, Daniel M., et al.
Publicado: (2020)

Molecular Analysis of Cystic Fibrosis Patients in Hungary – An Update to the Mutational Spectrum
por: Ivády, Gergely, et al.
Publicado: (2015)

Will Regulatory and Financial Considerations Dampen Innovation in the Clinical Microbiology Laboratory?
por: Gilligan, Peter H., et al.
Publicado: (2016)

Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis
por: Kotnik Pirš, Ana, et al.
Publicado: (2016)

Update on host-pathogen interactions in cystic fibrosis lung disease
por: Hector, Andreas, et al.
Publicado: (2016)

An update on methods for assessing bone quality and health in Cystic fibrosis
por: Williams, Kristen M., et al.
Publicado: (2021)

2663. Impact of Pre-Transplant Microbiology on Acute Outcomes in Cystic Fibrosis Patients Receiving Bilateral Lung Transplants
por: (Michael) Ji, Xincheng, et al.
Publicado: (2019)

Role of Inhalational Aztreonam Lysine in Lower Airway Infections in Cystic Fibrosis: An Updated Literature Review
por: Zeb, Mehwish, et al.
Publicado: (2022)

Diagnostic contribution of molecular analysis of the cystic fibrosis transmembrane conductance regulator gene in patients suspected of having mild or atypical cystic fibrosis
por: Dal'Maso, Vinícius Buaes, et al.
Publicado: (2013)

Chronic rhinosinusitis and nasal polyposis in cystic fibrosis: update on diagnosis and treatment
por: Kang, Suzie Hyeona, et al.
Publicado: (2015)

Diagnostic imaging in adult non-cystic fibrosis bronchiectasis
por: Juliusson, Gunnar, et al.
Publicado: (2019)

Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
por: DeCelie-Germana, Joan Kathleen, et al.
Publicado: (2023)

Viral respiratory infections in cystic fibrosis
por: van Ewijk, Bart E., et al.
Publicado: (2005)

Viral infections of the respiratory tract in patients with cystic fibrosis
por: Przyklenk, B., et al.
Publicado: (1988)

Etiology, Clinical, Radiological, and Microbiological Profile of Patients with Non-cystic Fibrosis Bronchiectasis at a Tertiary Care Hospital of Pakistan
por: Sharif, Nadia, et al.
Publicado: (2020)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry
por: Vongthilath, Réchana, et al.
Publicado: (2019)

Bacterial activity in cystic fibrosis lung infections
por: Rogers, Geraint B, et al.
Publicado: (2005)

How Clinically Efficient Is Lumacaftor/Ivacaftor for Cystic Fibrosis Patients? An Updated Literature Review
por: Perveen, Sumera, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p6imv4im6h4bo6mgrtbs1v2kmd